Further, lipopolysaccharide (LPS)-induced acute lung injury (ALI) studies in mice demonstrated that our lead is more efficacious than known sEH inhibitor AUDA in reducing the gene expressions of several inflammatory cytokines in vivo. The gene discussed is EPHX2; the disease is acute lung injury.